Be the first to like this
As pharma companies find it more difficult to connect with physicians and KOLs, advances and access to technology have opened doors for bio-pharmaceutical companies to adapt and enhance new processes and tools for superior performance and gain competitive edge in the market. Thus, the iPad has become a popular tool for many bio-pharmaceutical companies. However, implementing the iPad requires effective planning, resources and training in order to make a successful investment.
Best Practices LLC's study identifies the best practices and measures effectiveness for successful deployment of iPads to Medical Science Liaisons (MSLs). This study investigates how Medical Affairs functions in pharmaceutical companies are using iPads with their MSLs.